{"id":358325,"date":"2025-08-29T12:14:01","date_gmt":"2025-08-29T12:14:01","guid":{"rendered":"https:\/\/pocketoption.com\/blog\/how-to-buy-silence-therapeutics\/"},"modified":"2025-08-29T12:14:01","modified_gmt":"2025-08-29T12:14:01","slug":"how-to-buy-silence-therapeutics","status":"publish","type":"post","link":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-silence-therapeutics\/","title":{"rendered":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Silence Therapeutics plc (SLN) &#8211; \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Silence Therapeutics plc (SLN)"},"content":{"rendered":"<div id=\"root\"><div id=\"wrap-img-root\">text<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>text<\/p>\n","protected":false},"author":129,"featured_media":334081,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12837],"tags":[40],"class_list":["post-358325","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-signal","tag-signal"],"acf":{"h1":"C\u00e1ch Mua C\u1ed5 Phi\u1ebfu Silence Therapeutics plc (SLN) - \u0110\u1ea7u T\u01b0 V\u00e0o C\u1ed5 Phi\u1ebfu Silence Therapeutics plc (SLN)","h1_source":{"label":"H1","type":"text","formatted_value":"C\u00e1ch Mua C\u1ed5 Phi\u1ebfu Silence Therapeutics plc (SLN) - \u0110\u1ea7u T\u01b0 V\u00e0o C\u1ed5 Phi\u1ebfu Silence Therapeutics plc (SLN)"},"description":"T\u00ecm hi\u1ec3u c\u00e1ch mua c\u1ed5 phi\u1ebfu Silence Therapeutics plc (SLN) v\u00e0 \u0111\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu c\u00f4ng ngh\u1ec7 sinh h\u1ecdc s\u00e1ng t\u1ea1o n\u00e0y. Kh\u00e1m ph\u00e1 gi\u00e1 hi\u1ec7n t\u1ea1i, xu h\u01b0\u1edbng v\u00e0 c\u01a1 h\u1ed9i \u0111\u1ea7u t\u01b0 n\u0103m 2025.","description_source":{"label":"Description","type":"textarea","formatted_value":"T\u00ecm hi\u1ec3u c\u00e1ch mua c\u1ed5 phi\u1ebfu Silence Therapeutics plc (SLN) v\u00e0 \u0111\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu c\u00f4ng ngh\u1ec7 sinh h\u1ecdc s\u00e1ng t\u1ea1o n\u00e0y. Kh\u00e1m ph\u00e1 gi\u00e1 hi\u1ec7n t\u1ea1i, xu h\u01b0\u1edbng v\u00e0 c\u01a1 h\u1ed9i \u0111\u1ea7u t\u01b0 n\u0103m 2025."},"intro":"H\u00e3y t\u01b0\u1edfng t\u01b0\u1ee3ng b\u1ea1n s\u1edf h\u1eefu m\u1ed9t ph\u1ea7n c\u1ee7a b\u01b0\u1edbc \u0111\u1ed9t ph\u00e1 ti\u1ebfp theo trong y h\u1ecdc di truy\u1ec1n. Silence Therapeutics (SLN) kh\u00f4ng ch\u1ec9 l\u00e0 m\u1ed9t c\u1ed5 phi\u1ebfu c\u00f4ng ngh\u1ec7 sinh h\u1ecdc th\u00f4ng th\u01b0\u1eddng \u2014 \u0111\u00e2y l\u00e0 ng\u01b0\u1eddi ti\u00ean phong trong c\u00f4ng ngh\u1ec7 can thi\u1ec7p RNA c\u00f3 th\u1ec3 c\u00e1ch m\u1ea1ng h\u00f3a c\u00e1ch ch\u00fang ta \u0111i\u1ec1u tr\u1ecb c\u00e1c b\u1ec7nh hi\u1ebfm. V\u1edbi n\u1ec1n t\u1ea3ng siRNA ti\u00ean ti\u1ebfn nh\u1eafm v\u00e0o b\u1ec7nh \u0111a h\u1ed3ng c\u1ea7u nguy\u00ean ph\u00e1t v\u00e0 c\u00e1c b\u1ec7nh tim m\u1ea1ch, c\u00f4ng ty n\u00e0y \u0111\u1ea1i di\u1ec7n cho t\u01b0\u01a1ng lai c\u1ee7a y h\u1ecdc ch\u00ednh x\u00e1c. H\u00e3y c\u00f9ng kh\u00e1m ph\u00e1 l\u00fd do t\u1ea1i sao SLN c\u00f3 th\u1ec3 l\u00e0 c\u00e1nh c\u1eeda d\u1eabn b\u1ea1n v\u00e0o cu\u1ed9c c\u00e1ch m\u1ea1ng c\u00f4ng ngh\u1ec7 sinh h\u1ecdc v\u00e0 c\u00e1ch bi\u1ebfn n\u00f3 th\u00e0nh m\u1ed9t ph\u1ea7n trong h\u00e0nh tr\u00ecnh \u0111\u1ea7u t\u01b0 c\u1ee7a b\u1ea1n.","intro_source":{"label":"Intro","type":"text","formatted_value":"H\u00e3y t\u01b0\u1edfng t\u01b0\u1ee3ng b\u1ea1n s\u1edf h\u1eefu m\u1ed9t ph\u1ea7n c\u1ee7a b\u01b0\u1edbc \u0111\u1ed9t ph\u00e1 ti\u1ebfp theo trong y h\u1ecdc di truy\u1ec1n. Silence Therapeutics (SLN) kh\u00f4ng ch\u1ec9 l\u00e0 m\u1ed9t c\u1ed5 phi\u1ebfu c\u00f4ng ngh\u1ec7 sinh h\u1ecdc th\u00f4ng th\u01b0\u1eddng \u2014 \u0111\u00e2y l\u00e0 ng\u01b0\u1eddi ti\u00ean phong trong c\u00f4ng ngh\u1ec7 can thi\u1ec7p RNA c\u00f3 th\u1ec3 c\u00e1ch m\u1ea1ng h\u00f3a c\u00e1ch ch\u00fang ta \u0111i\u1ec1u tr\u1ecb c\u00e1c b\u1ec7nh hi\u1ebfm. V\u1edbi n\u1ec1n t\u1ea3ng siRNA ti\u00ean ti\u1ebfn nh\u1eafm v\u00e0o b\u1ec7nh \u0111a h\u1ed3ng c\u1ea7u nguy\u00ean ph\u00e1t v\u00e0 c\u00e1c b\u1ec7nh tim m\u1ea1ch, c\u00f4ng ty n\u00e0y \u0111\u1ea1i di\u1ec7n cho t\u01b0\u01a1ng lai c\u1ee7a y h\u1ecdc ch\u00ednh x\u00e1c. H\u00e3y c\u00f9ng kh\u00e1m ph\u00e1 l\u00fd do t\u1ea1i sao SLN c\u00f3 th\u1ec3 l\u00e0 c\u00e1nh c\u1eeda d\u1eabn b\u1ea1n v\u00e0o cu\u1ed9c c\u00e1ch m\u1ea1ng c\u00f4ng ngh\u1ec7 sinh h\u1ecdc v\u00e0 c\u00e1ch bi\u1ebfn n\u00f3 th\u00e0nh m\u1ed9t ph\u1ea7n trong h\u00e0nh tr\u00ecnh \u0111\u1ea7u t\u01b0 c\u1ee7a b\u1ea1n."},"body_html":"<h2>Gi\u00e1 C\u1ed5 Phi\u1ebfu Hi\u1ec7n T\u1ea1i v\u00e0 C\u00e1c Ng\u00e0y Quan Tr\u1ecdng<\/h2> <p>T\u00ednh \u0111\u1ebfn ng\u00e0y 29 th\u00e1ng 8 n\u0103m 2025, Silence Therapeutics plc (SLN) giao d\u1ecbch \u1edf m\u1ee9c <strong>5,10 USD<\/strong> m\u1ed7i c\u1ed5 phi\u1ebfu. H\u00e3y \u0111\u00e1nh d\u1ea5u l\u1ecbch c\u1ee7a b\u1ea1n v\u00e0o ng\u00e0y <strong>13 th\u00e1ng 11 n\u0103m 2025<\/strong> \u2014 \u0111\u00e2y l\u00e0 ng\u00e0y c\u00f4ng ty c\u00f4ng b\u1ed1 b\u00e1o c\u00e1o l\u1ee3i nhu\u1eadn qu\u00fd 3, v\u00e0 theo l\u1ecbch s\u1eed, c\u00e1c th\u00f4ng b\u00e1o n\u00e0y th\u01b0\u1eddng t\u1ea1o ra bi\u1ebfn \u0111\u1ed9ng gi\u00e1 \u0111\u00e1ng k\u1ec3.<\/p> <p>B\u00e1o c\u00e1o l\u1ee3i nhu\u1eadn g\u1ea7n nh\u1ea5t v\u00e0o ng\u00e0y 7 th\u00e1ng 8 n\u0103m 2025 cho th\u1ea5y c\u00f4ng ty b\u00e1o c\u00e1o EPS -0,54 USD v\u1edbi doanh thu 0,22 tri\u1ec7u USD (<a href=\"https:\/\/www.marketbeat.com\/earnings\/reports\/2025-8-7-silence-therapeutics-plc-stock\/\">B\u00e1o c\u00e1o L\u1ee3i Nhu\u1eadn MarketBeat<\/a>). C\u00e1c qu\u00fd tr\u01b0\u1edbc \u0111\u00e3 ch\u1ee9ng minh c\u00e1ch c\u00e1c c\u1eadp nh\u1eadt th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng c\u00f3 th\u1ec3 \u1ea3nh h\u01b0\u1edfng m\u1ea1nh \u0111\u1ebfn \u0111\u1ecbnh gi\u00e1 c\u1ee7a SLN.<\/p> <h3>Ph\u00e2n T\u00edch T\u00e1c \u0110\u1ed9ng L\u1ee3i Nhu\u1eadn L\u1ecbch S\u1eed<\/h3> <p>Xem x\u00e9t c\u00e1c m\u1eabu hi\u1ec7u su\u1ea5t g\u1ea7n \u0111\u00e2y:<\/p> <ul> <li><strong>7 th\u00e1ng 8 n\u0103m 2025<\/strong>: L\u1ee3i nhu\u1eadn qu\u00fd 2 - C\u1ed5 phi\u1ebfu ph\u1ea3n \u1ee9ng v\u1edbi s\u1ef1 bi\u1ebfn \u0111\u1ed9ng t\u0103ng quanh c\u00e1c c\u1eadp nh\u1eadt th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng<\/li> <li><strong>Th\u00e1ng 5 n\u0103m 2025<\/strong>: L\u1ee3i nhu\u1eadn qu\u00fd 1 - Doanh thu 142.000 USD v\u1edbi tr\u1ecdng t\u00e2m k\u00e9o d\u00e0i v\u1ecb th\u1ebf ti\u1ec1n m\u1eb7t \u0111\u1ebfn n\u0103m 2028<\/li> <li><strong>Th\u00e1ng 1 n\u0103m 2025<\/strong>: Th\u1ea5t b\u1ea1i th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng g\u00e2y gi\u1ea3m 21,81% trong m\u1ed9t ng\u00e0y (<a href=\"https:\/\/tickeron.com\/trading-investing-101\/slxn-stock-surges-2414-in-2025-what-drove-the-rally-and-can-it-continue\/\">Ph\u00e2n t\u00edch Tickeron<\/a>)<\/li> <\/ul> <p>M\u1eabu h\u00ecnh r\u00f5 r\u00e0ng: d\u1eef li\u1ec7u l\u00e2m s\u00e0ng t\u00edch c\u1ef1c th\u00fac \u0111\u1ea9y c\u00e1c \u0111\u1ee3t t\u0103ng gi\u00e1, trong khi th\u1ea5t b\u1ea1i g\u00e2y ra s\u1ee5t gi\u1ea3m m\u1ea1nh. B\u00e1o c\u00e1o l\u1ee3i nhu\u1eadn th\u00e1ng 11 n\u00e0y s\u1ebd \u0111\u1eb7c bi\u1ec7t quan tr\u1ecdng v\u00ec c\u00f3 th\u1ec3 bao g\u1ed3m c\u1eadp nh\u1eadt v\u1ec1 ti\u1ebfn \u0111\u1ed9 tuy\u1ec3n d\u1ee5ng nghi\u00ean c\u1ee9u giai \u0111o\u1ea1n 2 SANRECO.<\/p> [cta_green text=\"B\u1eaft \u0111\u1ea7u giao d\u1ecbch\"]<h2>H\u00e0nh Tr\u00ecnh Gi\u00e1 S\u00e1u Th\u00e1ng: T\u0103ng Gi\u1ea3m M\u1ea1nh M\u1ebd V\u1edbi Ti\u1ec1m N\u0103ng<\/h2> <p>Silence Therapeutics \u0111\u00e3 \u0111\u01b0a c\u00e1c nh\u00e0 \u0111\u1ea7u t\u01b0 tr\u1ea3i qua m\u1ed9t chuy\u1ebfn \u0111i \u0111\u1ea7y bi\u1ebfn \u0111\u1ed9ng trong s\u00e1u th\u00e1ng qua, gi\u1ea3m t\u1ed5ng c\u1ed9ng <strong>74,91%<\/strong> nh\u01b0ng th\u1ec3 hi\u1ec7n s\u1ef1 ph\u1ee5c h\u1ed3i \u1ea5n t\u01b0\u1ee3ng v\u1edbi m\u1ee9c t\u0103ng <strong>96,5%<\/strong> trong ba th\u00e1ng g\u1ea7n \u0111\u00e2y (<a href=\"https:\/\/stockanalysis.com\/stocks\/sln\/forecast\/\">Ph\u00e2n T\u00edch C\u1ed5 Phi\u1ebfu<\/a>).<\/p> <p><strong>Th\u00e1ng 1-3 n\u0103m 2025<\/strong>: Giai \u0111o\u1ea1n b\u1eaft \u0111\u1ea7u v\u1edbi th\u1ea5t v\u1ecdng th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng khi\u1ebfn c\u1ed5 phi\u1ebfu lao d\u1ed1c xu\u1ed1ng g\u1ea7n m\u1ee9c th\u1ea5p nh\u1ea5t trong 52 tu\u1ea7n. C\u1ed5 phi\u1ebfu ch\u1ea1m \u0111\u00e1y 1,97 USD, t\u1ea1o ra \u0111i\u1ec3m \u0111\u00e1y m\u00e0 nhi\u1ec1u nh\u00e0 ph\u00e2n t\u00edch hi\u1ec7n coi l\u00e0 ti\u1ec1m n\u0103ng.<\/p> <p><strong>Th\u00e1ng 4-6 n\u0103m 2025<\/strong>: Ph\u1ee5c h\u1ed3i d\u1ea7n b\u1eaft \u0111\u1ea7u khi c\u00f4ng ty tr\u00ecnh b\u00e0y d\u1eef li\u1ec7u giai \u0111o\u1ea1n 1 \u0111\u1ea7y h\u1ee9a h\u1eb9n cho divesiran t\u1ea1i c\u00e1c h\u1ed9i ngh\u1ecb y khoa. C\u1ed5 phi\u1ebfu t\u0103ng t\u1eeb v\u00f9ng 2-3 USD tr\u1edf l\u1ea1i m\u1ee9c 4-5 USD.<\/p> <p><strong>Th\u00e1ng 7-8 n\u0103m 2025<\/strong>: \u0110\u00e0 t\u0103ng th\u1ef1c s\u1ef1 \u0111\u01b0\u1ee3c x\u00e2y d\u1ef1ng khi nghi\u00ean c\u1ee9u giai \u0111o\u1ea1n 2 SANRECO v\u01b0\u1ee3t qu\u00e1 50% tuy\u1ec3n d\u1ee5ng v\u00e0 ph\u1ea3n h\u1ed3i t\u00edch c\u1ef1c t\u1eeb c\u01a1 quan qu\u1ea3n l\u00fd cho zerlasiran. C\u1ed5 phi\u1ebfu \u0111\u1ea1t 6,20 USD v\u00e0o cu\u1ed1i th\u00e1ng 7 tr\u01b0\u1edbc khi \u1ed5n \u0111\u1ecbnh quanh m\u1ee9c hi\u1ec7n t\u1ea1i.<\/p> <p>Bi\u1ebfn \u0111\u1ed9ng n\u00e0y kh\u00f4ng d\u00e0nh cho ng\u01b0\u1eddi y\u1ebfu tim nh\u01b0ng t\u1ea1o c\u01a1 h\u1ed9i cho c\u00e1c nh\u00e0 \u0111\u1ea7u t\u01b0 chi\u1ebfn l\u01b0\u1ee3c hi\u1ec3u chu k\u1ef3 c\u00f4ng ngh\u1ec7 sinh h\u1ecdc.<\/p> <h2>D\u1ef1 B\u00e1o Gi\u00e1: Tri\u1ec3n V\u1ecdng 2025-2030<\/h2> <p>D\u1ef1a tr\u00ean s\u1ef1 \u0111\u1ed3ng thu\u1eadn c\u1ee7a c\u00e1c nh\u00e0 ph\u00e2n t\u00edch hi\u1ec7n t\u1ea1i v\u00e0 c\u00e1c c\u1ed9t m\u1ed1c l\u00e2m s\u00e0ng, t\u01b0\u01a1ng lai c\u00f3 th\u1ec3 nh\u01b0 sau:<\/p> <ul> <li><strong>Cu\u1ed1i n\u0103m 2025<\/strong>: M\u1ee5c ti\u00eau trung b\u00ecnh <strong>33,83 USD<\/strong> (t\u0103ng 563%) v\u1edbi \u01b0\u1edbc t\u00ednh cao l\u00ean \u0111\u1ebfn <strong>75,00 USD<\/strong> (<a href=\"https:\/\/www.marketbeat.com\/stocks\/NASDAQ\/SLN\/forecast\/\">D\u1ef1 B\u00e1o MarketBeat<\/a>). \u0110\u1ed9ng l\u1ef1c ch\u00ednh s\u1ebd l\u00e0 ho\u00e0n th\u00e0nh tuy\u1ec3n d\u1ee5ng \u0111\u1ea7y \u0111\u1ee7 giai \u0111o\u1ea1n 2 SANRECO.<\/li> <li><strong>D\u1ef1 b\u00e1o 2026<\/strong>: V\u00f9ng <strong>40-60 USD<\/strong> gi\u1ea3 \u0111\u1ecbnh d\u1eef li\u1ec7u giai \u0111o\u1ea1n 2 t\u00edch c\u1ef1c v\u00e0 kh\u1ea3 n\u0103ng c\u00f4ng b\u1ed1 h\u1ee3p t\u00e1c ph\u00e1t tri\u1ec3n giai \u0111o\u1ea1n 3 cho zerlasiran.<\/li> <li><strong>Tri\u1ec3n v\u1ecdng 2028<\/strong>: Ti\u1ec1m n\u0103ng <strong>80-120 USD<\/strong> n\u1ebfu divesiran \u0111\u01b0\u1ee3c ph\u00ea duy\u1ec7t v\u00e0 th\u00e0nh c\u00f4ng th\u01b0\u01a1ng m\u1ea1i trong \u0111i\u1ec1u tr\u1ecb \u0111a h\u1ed3ng c\u1ea7u nguy\u00ean ph\u00e1t.<\/li> <li><strong>T\u1ea7m nh\u00ecn 2030<\/strong>: C\u00f3 th\u1ec3 \u0111\u1ea1t <strong>150 USD+<\/strong> v\u1edbi nhi\u1ec1u li\u1ec7u ph\u00e1p \u0111\u01b0\u1ee3c ph\u00ea duy\u1ec7t v\u00e0 m\u1edf r\u1ed9ng danh m\u1ee5c d\u1ef1a tr\u00ean n\u1ec1n t\u1ea3ng mRNAi GOLD\u2122 c\u1ee7a h\u1ecd.<\/li> <\/ul> <p><strong>K\u1ebft lu\u1eadn<\/strong>: MUA M\u1ea0NH cho c\u00e1c nh\u00e0 \u0111\u1ea7u t\u01b0 ch\u1ecbu r\u1ee7i ro v\u1edbi t\u1ea7m nh\u00ecn 3-5 n\u0103m.<\/p> <h2>Ph\u00e2n T\u00edch R\u1ee7i Ro: \u0110i\u1ec1u H\u01b0\u1edbng Bi\u1ebfn \u0110\u1ed9ng C\u00f4ng Ngh\u1ec7 Sinh H\u1ecdc<\/h2> <h3>C\u00e1c Y\u1ebfu T\u1ed1 R\u1ee7i Ro Cao<\/h3> <ul> <li><strong>R\u1ee7i Ro Th\u1ea5t B\u1ea1i Th\u1eed Nghi\u1ec7m L\u00e2m S\u00e0ng<\/strong>: Gi\u1ea3m 21,81% v\u00e0o th\u00e1ng 1 n\u0103m 2025 cho th\u1ea5y k\u1ebft qu\u1ea3 ti\u00eau c\u1ef1c c\u00f3 th\u1ec3 g\u00e2y thi\u1ec7t h\u1ea1i l\u1edbn (<a href=\"https:\/\/tickeron.com\/trading-investing-101\/slxn-stock-surges-2414-in-2025-what-drove-the-rally-and-can-it-continue\/\">Tickeron<\/a>)<\/li> <li><strong>Kh\u1ea3 N\u0103ng T\u00e0i Ch\u00ednh B\u1ec1n V\u1eefng<\/strong>: Bi\u00ean l\u1ee3i nhu\u1eadn \u00e2m v\u00e0 t\u1ed1c \u0111\u1ed9 ti\u00eau ti\u1ec1n m\u1eb7t cao c\u1ea7n \u0111\u01b0\u1ee3c theo d\u00f5i ch\u1eb7t ch\u1ebd<\/li> <li><strong>R\u00e0o C\u1ea3n Ph\u00e1p L\u00fd<\/strong>: Ph\u00ea duy\u1ec7t FDA kh\u00f4ng bao gi\u1edd \u0111\u01b0\u1ee3c \u0111\u1ea3m b\u1ea3o, \u0111\u1eb7c bi\u1ec7t v\u1edbi c\u00e1c li\u1ec7u ph\u00e1p \u0111\u1ea7u ti\u00ean trong lo\u1ea1i<\/li> <li><strong>C\u1ea1nh Tranh<\/strong>: C\u00e1c c\u00f4ng ty d\u01b0\u1ee3c l\u1edbn h\u01a1n ph\u00e1t tri\u1ec3n c\u00e1c li\u1ec7u ph\u00e1p nh\u1eafm m\u1ee5c ti\u00eau KRAS t\u01b0\u01a1ng t\u1ef1<\/li> <\/ul> <h3>Y\u1ebfu T\u1ed1 T\u00edch C\u1ef1c Cho N\u0103m 2025<\/h3> <ul> <li><strong>Ho\u00e0n Th\u00e0nh Giai \u0110o\u1ea1n 2 SANRECO<\/strong>: D\u1ef1 ki\u1ebfn tuy\u1ec3n \u0111\u1ee7 v\u00e0o cu\u1ed1i n\u0103m 2025<\/li> <li><strong>C\u01a1 H\u1ed9i H\u1ee3p T\u00e1c<\/strong>: \u0110ang th\u1ea3o lu\u1eadn t\u00edch c\u1ef1c cho ph\u00e1t tri\u1ec3n giai \u0111o\u1ea1n 3 zerlasiran<\/li> <li><strong>D\u1eef Li\u1ec7u Divesiran<\/strong>: K\u1ebft qu\u1ea3 giai \u0111o\u1ea1n 1 b\u1ed5 sung cho th\u1ea5y ti\u1ec1m n\u0103ng \u0111i\u1ec1u tr\u1ecb \u0111a h\u1ed3ng c\u1ea7u nguy\u00ean ph\u00e1t<\/li> <li><strong>V\u1ed1n D\u1ef1 Tr\u1eef<\/strong>: V\u1ecb th\u1ebf ti\u1ec1n m\u1eb7t tr\u00ean 136 tri\u1ec7u USD k\u00e9o d\u00e0i \u0111\u1ebfn n\u0103m 2028<\/li> <\/ul> <h2>Ng\u01b0\u1eddi M\u1edbi B\u1eaft \u0110\u1ea7u N\u00ean L\u00e0m G\u00ec H\u00f4m Nay?<\/h2> <ol> <li><strong>B\u1eaft \u0110\u1ea7u Nh\u1ecf<\/strong>: Ph\u00e2n b\u1ed5 kh\u00f4ng qu\u00e1 2-5% danh m\u1ee5c cho c\u00e1c c\u1ed5 phi\u1ebfu c\u00f4ng ngh\u1ec7 sinh h\u1ecdc r\u1ee7i ro cao nh\u01b0 SLN<\/li> <li><strong>Trung B\u00ecnh Gi\u00e1 \u0110\u00f4 La<\/strong>: Thay v\u00ec mua m\u1ed9t l\u1ea7n l\u1edbn, h\u00e3y c\u00e2n nh\u1eafc \u0111\u1ea7u t\u01b0 nh\u1ecf \u0111\u1ec1u \u0111\u1eb7n \u0111\u1ec3 gi\u1ea3m r\u1ee7i ro th\u1eddi \u0111i\u1ec3m<\/li> <li><strong>\u0110\u1eb7t M\u1ee9c C\u1ea3nh B\u00e1o Gi\u00e1<\/strong>: \u0110\u1eb7t c\u1ea3nh b\u00e1o gi\u00e1 t\u1ea1i 4,50 USD (h\u1ed7 tr\u1ee3) v\u00e0 6,50 USD (kh\u00e1ng c\u1ef1) \u0111\u1ec3 b\u1eaft c\u01a1 h\u1ed9i<\/li> <li><strong>Theo D\u00f5i C\u00e1c C\u1ed9t M\u1ed1c L\u00e2m S\u00e0ng<\/strong>: \u0110\u00e1nh d\u1ea5u ng\u00e0y c\u00f4ng b\u1ed1 l\u1ee3i nhu\u1eadn 13 th\u00e1ng 11 v\u00e0 theo d\u00f5i c\u1eadp nh\u1eadt tuy\u1ec3n d\u1ee5ng SANRECO<\/li> <\/ol> <p>L\u1eddi khuy\u00ean h\u00e0i h\u01b0\u1edbc t\u1eeb c\u00e1c nh\u00e0 \u0111\u1ea7u t\u01b0 k\u1ef3 c\u1ef1u: \"Giao d\u1ecbch SLN gi\u1ed1ng nh\u01b0 h\u1eb9n h\u00f2 v\u1edbi m\u1ed9t nh\u00e0 khoa h\u1ecdc t\u00e0i ba \u2014 c\u1ef1c k\u1ef3 th\u00fa v\u1ecb khi c\u00e1c th\u00ed nghi\u1ec7m th\u00e0nh c\u00f4ng, nh\u01b0ng h\u00e3y chu\u1ea9n b\u1ecb cho m\u1ed9t v\u00e0i th\u1ea5t b\u1ea1i n\u1ed5 tung tr\u00ean \u0111\u01b0\u1eddng \u0111i!\"<\/p> <h2>C\u00e1ch Mua C\u1ed5 Phi\u1ebfu Silence Therapeutics plc (SLN) - T\u1eebng B\u01b0\u1edbc<\/h2> <table> <thead> <tr><th>B\u01b0\u1edbc<\/th><th>H\u00e0nh \u0110\u1ed9ng<\/th><th>T\u1ea1i Sao Quan Tr\u1ecdng<\/th><\/tr> <\/thead> <tbody> <tr><td>1<\/td><td>Ch\u1ecdn N\u1ec1n T\u1ea3ng Giao D\u1ecbch<\/td><td>\u0110\u1ea3m b\u1ea3o n\u1ec1n t\u1ea3ng c\u00f3 danh s\u00e1ch NASDAQ v\u00e0 h\u1ed7 tr\u1ee3 mua c\u1ed5 phi\u1ebfu l\u1ebb<\/td><\/tr> <tr><td>2<\/td><td>Ho\u00e0n Th\u00e0nh X\u00e1c Minh T\u00e0i Kho\u1ea3n<\/td><td>H\u1ea7u h\u1ebft n\u1ec1n t\u1ea3ng y\u00eau c\u1ea7u ID v\u00e0 b\u1eb1ng ch\u1ee9ng \u0111\u1ecba ch\u1ec9<\/td><\/tr> <tr><td>3<\/td><td>N\u1ea1p Ti\u1ec1n V\u00e0o T\u00e0i Kho\u1ea3n<\/td><td>B\u1eaft \u0111\u1ea7u v\u1edbi s\u1ed1 ti\u1ec1n b\u1ea1n c\u1ea3m th\u1ea5y tho\u1ea3i m\u00e1i khi r\u1ee7i ro<\/td><\/tr> <tr><td>4<\/td><td>T\u00ecm ki\u1ebfm \"SLN\"<\/td><td>S\u1eed d\u1ee5ng m\u00e3 ch\u1ee9ng kho\u00e1n, kh\u00f4ng ph\u1ea3i t\u00ean \u0111\u1ea7y \u0111\u1ee7 c\u00f4ng ty<\/td><\/tr> <tr><td>5<\/td><td>Ch\u1ecdn Lo\u1ea1i L\u1ec7nh<\/td><td>D\u00f9ng l\u1ec7nh gi\u1edbi h\u1ea1n \u0111\u1ec3 ki\u1ec3m so\u00e1t gi\u00e1 v\u00e0o<\/td><\/tr> <tr><td>6<\/td><td>Xem L\u1ea1i Chi Ti\u1ebft L\u1ec7nh<\/td><td>Ki\u1ec3m tra ph\u00ed hoa h\u1ed3ng v\u00e0 ng\u00e0y thanh to\u00e1n<\/td><\/tr> <tr><td>7<\/td><td>Th\u1ef1c Hi\u1ec7n Mua<\/td><td>X\u00e1c nh\u1eadn giao d\u1ecbch v\u00e0 thi\u1ebft l\u1eadp theo d\u00f5i danh m\u1ee5c<\/td><\/tr> <\/tbody> <\/table> <h2>T\u1ea1i Sao Pocket Option Thu H\u00fat Nh\u00e0 \u0110\u1ea7u T\u01b0 M\u1edbi<\/h2> <p>\u0110\u1ed1i v\u1edbi nh\u1eefng ng\u01b0\u1eddi m\u1edbi b\u1eaft \u0111\u1ea7u h\u00e0nh tr\u00ecnh \u0111\u1ea7u t\u01b0, Pocket Option cung c\u1ea5p nhi\u1ec1u l\u1ee3i th\u1ebf gi\u00fap vi\u1ec7c tham gia th\u1ecb tr\u01b0\u1eddng b\u1edbt \u00e1p l\u1ef1c:<\/p> <ul> <li><strong>S\u1ed1 Ti\u1ec1n N\u1ea1p T\u1ed1i Thi\u1ec3u Ch\u1ec9 5 USD<\/strong> - B\u1ea1n c\u00f3 th\u1ec3 b\u1eaft \u0111\u1ea7u v\u1edbi g\u1ea7n nh\u01b0 b\u1ea5t k\u1ef3 s\u1ed1 ti\u1ec1n n\u00e0o, r\u1ea5t ph\u00f9 h\u1ee3p \u0111\u1ec3 th\u1eed nghi\u1ec7m chi\u1ebfn l\u01b0\u1ee3c m\u00e0 kh\u00f4ng c\u1ea7n cam k\u1ebft t\u00e0i ch\u00ednh l\u1edbn.<\/li> <li><strong>Quy Tr\u00ecnh X\u00e1c Minh Nhanh<\/strong> - Ho\u00e0n th\u00e0nh KYC ch\u1ec9 v\u1edbi m\u1ed9t t\u00e0i li\u1ec7u t\u1ea3i l\u00ean v\u00e0 b\u1eaft \u0111\u1ea7u giao d\u1ecbch trong v\u00e0i ph\u00fat thay v\u00ec v\u00e0i ng\u00e0y.<\/li> <li><strong>Nhi\u1ec1u Ph\u01b0\u01a1ng Th\u1ee9c R\u00fat Ti\u1ec1n<\/strong> - Truy c\u1eadp l\u1ee3i nhu\u1eadn qua h\u00e0ng tr\u0103m ph\u01b0\u01a1ng th\u1ee9c bao g\u1ed3m ti\u1ec1n \u0111i\u1ec7n t\u1eed, v\u00ed \u0111i\u1ec7n t\u1eed v\u00e0 ng\u00e2n h\u00e0ng truy\u1ec1n th\u1ed1ng.<\/li> <\/ul> <p>Giao di\u1ec7n th\u00e2n thi\u1ec7n v\u1edbi ng\u01b0\u1eddi d\u00f9ng c\u00f9ng v\u1edbi r\u00e0o c\u1ea3n gia nh\u1eadp th\u1ea5p khi\u1ebfn n\u1ec1n t\u1ea3ng n\u00e0y l\u00fd t\u01b0\u1edfng cho c\u00e1c nh\u00e0 \u0111\u1ea7u t\u01b0 mu\u1ed1n x\u00e2y d\u1ef1ng v\u1ecb th\u1ebf trong c\u00e1c c\u00f4ng ty ti\u1ec1m n\u0103ng nh\u01b0 Silence Therapeutics m\u00e0 kh\u00f4ng b\u1ecb ph\u1ee9c t\u1ea1p qu\u00e1 m\u1ee9c.<\/p> <h2>T\u1ed5ng Quan C\u00f4ng Ty: Silence Therapeutics N\u0103m 2025<\/h2> <p>Silence Therapeutics \u0111\u1ee9ng \u1edf v\u1ecb tr\u00ed ti\u00ean phong trong \u0111\u1ed5i m\u1edbi y h\u1ecdc di truy\u1ec1n. C\u00f4ng ty chuy\u00ean v\u1ec1 li\u1ec7u ph\u00e1p siRNA (RNA can thi\u1ec7p nh\u1ecf) s\u1eed d\u1ee5ng n\u1ec1n t\u1ea3ng \u0111\u1ed9c quy\u1ec1n mRNAi GOLD\u2122 \u0111\u1ec3 nh\u1eafm ch\u00ednh x\u00e1c c\u00e1c gen g\u00e2y b\u1ec7nh.<\/p> <p><strong>Tr\u1ecdng T\u00e2m Hi\u1ec7n T\u1ea1i<\/strong>: \u0110\u1ea9y m\u1ea1nh ph\u00e1t tri\u1ec3n divesiran qua c\u00e1c th\u1eed nghi\u1ec7m giai \u0111o\u1ea1n 2 cho b\u1ec7nh \u0111a h\u1ed3ng c\u1ea7u nguy\u00ean ph\u00e1t, m\u1ed9t r\u1ed1i lo\u1ea1n m\u00e1u hi\u1ebfm \u1ea3nh h\u01b0\u1edfng kho\u1ea3ng 100.000 b\u1ec7nh nh\u00e2n ch\u1ec9 ri\u00eang t\u1ea1i M\u1ef9. Li\u1ec7u ph\u00e1p n\u00e0y c\u00f3 ti\u1ec1m n\u0103ng lo\u1ea1i b\u1ecf nhu c\u1ea7u l\u1ea5y m\u00e1u \u0111\u1ecbnh k\u1ef3 \u2014 c\u1ea3i thi\u1ec7n \u0111\u00e1ng k\u1ec3 ch\u1ea5t l\u01b0\u1ee3ng cu\u1ed9c s\u1ed1ng.<\/p> <p><strong>V\u1ecb Th\u1ebf Th\u1ecb Tr\u01b0\u1eddng<\/strong>: L\u00e0 m\u1ed9t c\u00f4ng ty c\u00f4ng ngh\u1ec7 sinh h\u1ecdc v\u1ed1n h\u00f3a nh\u1ecf v\u1edbi gi\u00e1 tr\u1ecb th\u1ecb tr\u01b0\u1eddng 291 tri\u1ec7u USD, SLN th\u1ec3 hi\u1ec7n s\u1ef1 v\u01b0\u1ee3t tr\u1ed9i v\u1ec1 \u0111\u1ed5i m\u1edbi c\u00f4ng ngh\u1ec7 trong khi duy tr\u00ec s\u1ef1 linh ho\u1ea1t \u0111\u1ec3 nhanh ch\u00f3ng \u0111i\u1ec1u ch\u1ec9nh d\u1ef1a tr\u00ean k\u1ebft qu\u1ea3 l\u00e2m s\u00e0ng.<\/p> <p><strong>S\u1ef1 Th\u1eadt Th\u00fa V\u1ecb N\u0103m 2025<\/strong>: Trung t\u00e2m nghi\u00ean c\u1ee9u c\u1ee7a Silence Therapeutics \u0111\u00e3 ph\u00e1t tri\u1ec3n m\u1ed9t h\u1ec7 th\u1ed1ng AI c\u00f3 th\u1ec3 d\u1ef1 \u0111o\u00e1n m\u00f4 h\u00ecnh g\u1eadp RNA v\u1edbi \u0111\u1ed9 ch\u00ednh x\u00e1c 94% \u2014 r\u00fat ng\u1eafn th\u1eddi gian ph\u00e1t tri\u1ec3n thu\u1ed1c h\u00e0ng th\u00e1ng v\u00e0 c\u00f3 th\u1ec3 ti\u1ebft ki\u1ec7m h\u00e0ng tri\u1ec7u USD chi ph\u00ed R&D. L\u1ee3i th\u1ebf c\u00f4ng ngh\u1ec7 n\u00e0y c\u00f3 th\u1ec3 c\u00e1ch m\u1ea1ng h\u00f3a t\u1ed1c \u0111\u1ed9 \u0111\u01b0a c\u00e1c li\u1ec7u ph\u00e1p m\u1edbi ra th\u1ecb tr\u01b0\u1eddng.<\/p>","body_html_source":{"label":"Body HTML","type":"wysiwyg","formatted_value":"<h2>Gi\u00e1 C\u1ed5 Phi\u1ebfu Hi\u1ec7n T\u1ea1i v\u00e0 C\u00e1c Ng\u00e0y Quan Tr\u1ecdng<\/h2>\n<p>T\u00ednh \u0111\u1ebfn ng\u00e0y 29 th\u00e1ng 8 n\u0103m 2025, Silence Therapeutics plc (SLN) giao d\u1ecbch \u1edf m\u1ee9c <strong>5,10 USD<\/strong> m\u1ed7i c\u1ed5 phi\u1ebfu. H\u00e3y \u0111\u00e1nh d\u1ea5u l\u1ecbch c\u1ee7a b\u1ea1n v\u00e0o ng\u00e0y <strong>13 th\u00e1ng 11 n\u0103m 2025<\/strong> \u2014 \u0111\u00e2y l\u00e0 ng\u00e0y c\u00f4ng ty c\u00f4ng b\u1ed1 b\u00e1o c\u00e1o l\u1ee3i nhu\u1eadn qu\u00fd 3, v\u00e0 theo l\u1ecbch s\u1eed, c\u00e1c th\u00f4ng b\u00e1o n\u00e0y th\u01b0\u1eddng t\u1ea1o ra bi\u1ebfn \u0111\u1ed9ng gi\u00e1 \u0111\u00e1ng k\u1ec3.<\/p>\n<p>B\u00e1o c\u00e1o l\u1ee3i nhu\u1eadn g\u1ea7n nh\u1ea5t v\u00e0o ng\u00e0y 7 th\u00e1ng 8 n\u0103m 2025 cho th\u1ea5y c\u00f4ng ty b\u00e1o c\u00e1o EPS -0,54 USD v\u1edbi doanh thu 0,22 tri\u1ec7u USD (<a href=\"https:\/\/www.marketbeat.com\/earnings\/reports\/2025-8-7-silence-therapeutics-plc-stock\/\">B\u00e1o c\u00e1o L\u1ee3i Nhu\u1eadn MarketBeat<\/a>). C\u00e1c qu\u00fd tr\u01b0\u1edbc \u0111\u00e3 ch\u1ee9ng minh c\u00e1ch c\u00e1c c\u1eadp nh\u1eadt th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng c\u00f3 th\u1ec3 \u1ea3nh h\u01b0\u1edfng m\u1ea1nh \u0111\u1ebfn \u0111\u1ecbnh gi\u00e1 c\u1ee7a SLN.<\/p>\n<h3>Ph\u00e2n T\u00edch T\u00e1c \u0110\u1ed9ng L\u1ee3i Nhu\u1eadn L\u1ecbch S\u1eed<\/h3>\n<p>Xem x\u00e9t c\u00e1c m\u1eabu hi\u1ec7u su\u1ea5t g\u1ea7n \u0111\u00e2y:<\/p>\n<ul>\n<li><strong>7 th\u00e1ng 8 n\u0103m 2025<\/strong>: L\u1ee3i nhu\u1eadn qu\u00fd 2 &#8211; C\u1ed5 phi\u1ebfu ph\u1ea3n \u1ee9ng v\u1edbi s\u1ef1 bi\u1ebfn \u0111\u1ed9ng t\u0103ng quanh c\u00e1c c\u1eadp nh\u1eadt th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng<\/li>\n<li><strong>Th\u00e1ng 5 n\u0103m 2025<\/strong>: L\u1ee3i nhu\u1eadn qu\u00fd 1 &#8211; Doanh thu 142.000 USD v\u1edbi tr\u1ecdng t\u00e2m k\u00e9o d\u00e0i v\u1ecb th\u1ebf ti\u1ec1n m\u1eb7t \u0111\u1ebfn n\u0103m 2028<\/li>\n<li><strong>Th\u00e1ng 1 n\u0103m 2025<\/strong>: Th\u1ea5t b\u1ea1i th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng g\u00e2y gi\u1ea3m 21,81% trong m\u1ed9t ng\u00e0y (<a href=\"https:\/\/tickeron.com\/trading-investing-101\/slxn-stock-surges-2414-in-2025-what-drove-the-rally-and-can-it-continue\/\">Ph\u00e2n t\u00edch Tickeron<\/a>)<\/li>\n<\/ul>\n<p>M\u1eabu h\u00ecnh r\u00f5 r\u00e0ng: d\u1eef li\u1ec7u l\u00e2m s\u00e0ng t\u00edch c\u1ef1c th\u00fac \u0111\u1ea9y c\u00e1c \u0111\u1ee3t t\u0103ng gi\u00e1, trong khi th\u1ea5t b\u1ea1i g\u00e2y ra s\u1ee5t gi\u1ea3m m\u1ea1nh. B\u00e1o c\u00e1o l\u1ee3i nhu\u1eadn th\u00e1ng 11 n\u00e0y s\u1ebd \u0111\u1eb7c bi\u1ec7t quan tr\u1ecdng v\u00ec c\u00f3 th\u1ec3 bao g\u1ed3m c\u1eadp nh\u1eadt v\u1ec1 ti\u1ebfn \u0111\u1ed9 tuy\u1ec3n d\u1ee5ng nghi\u00ean c\u1ee9u giai \u0111o\u1ea1n 2 SANRECO.<\/p>\n<div class=\"po-container po-container_width_article\">\n   <div class=\"po-cta-green__wrap\">\n      <a href=\"https:\/\/pocketoption.com\/vt\/register\/\" class=\"po-cta-green\">B\u1eaft \u0111\u1ea7u giao d\u1ecbch\n         <span class=\"po-cta-green__icon\">\n            <svg width=\"24\" height=\"24\" fill=\"none\" aria-hidden=\"true\">\n               <use href=\"#svg-arrow-cta\"><\/use>\n            <\/svg>\n         <\/span>\n      <\/a>\n   <\/div>\n<\/div>\n<h2>H\u00e0nh Tr\u00ecnh Gi\u00e1 S\u00e1u Th\u00e1ng: T\u0103ng Gi\u1ea3m M\u1ea1nh M\u1ebd V\u1edbi Ti\u1ec1m N\u0103ng<\/h2>\n<p>Silence Therapeutics \u0111\u00e3 \u0111\u01b0a c\u00e1c nh\u00e0 \u0111\u1ea7u t\u01b0 tr\u1ea3i qua m\u1ed9t chuy\u1ebfn \u0111i \u0111\u1ea7y bi\u1ebfn \u0111\u1ed9ng trong s\u00e1u th\u00e1ng qua, gi\u1ea3m t\u1ed5ng c\u1ed9ng <strong>74,91%<\/strong> nh\u01b0ng th\u1ec3 hi\u1ec7n s\u1ef1 ph\u1ee5c h\u1ed3i \u1ea5n t\u01b0\u1ee3ng v\u1edbi m\u1ee9c t\u0103ng <strong>96,5%<\/strong> trong ba th\u00e1ng g\u1ea7n \u0111\u00e2y (<a href=\"https:\/\/stockanalysis.com\/stocks\/sln\/forecast\/\">Ph\u00e2n T\u00edch C\u1ed5 Phi\u1ebfu<\/a>).<\/p>\n<p><strong>Th\u00e1ng 1-3 n\u0103m 2025<\/strong>: Giai \u0111o\u1ea1n b\u1eaft \u0111\u1ea7u v\u1edbi th\u1ea5t v\u1ecdng th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng khi\u1ebfn c\u1ed5 phi\u1ebfu lao d\u1ed1c xu\u1ed1ng g\u1ea7n m\u1ee9c th\u1ea5p nh\u1ea5t trong 52 tu\u1ea7n. C\u1ed5 phi\u1ebfu ch\u1ea1m \u0111\u00e1y 1,97 USD, t\u1ea1o ra \u0111i\u1ec3m \u0111\u00e1y m\u00e0 nhi\u1ec1u nh\u00e0 ph\u00e2n t\u00edch hi\u1ec7n coi l\u00e0 ti\u1ec1m n\u0103ng.<\/p>\n<p><strong>Th\u00e1ng 4-6 n\u0103m 2025<\/strong>: Ph\u1ee5c h\u1ed3i d\u1ea7n b\u1eaft \u0111\u1ea7u khi c\u00f4ng ty tr\u00ecnh b\u00e0y d\u1eef li\u1ec7u giai \u0111o\u1ea1n 1 \u0111\u1ea7y h\u1ee9a h\u1eb9n cho divesiran t\u1ea1i c\u00e1c h\u1ed9i ngh\u1ecb y khoa. C\u1ed5 phi\u1ebfu t\u0103ng t\u1eeb v\u00f9ng 2-3 USD tr\u1edf l\u1ea1i m\u1ee9c 4-5 USD.<\/p>\n<p><strong>Th\u00e1ng 7-8 n\u0103m 2025<\/strong>: \u0110\u00e0 t\u0103ng th\u1ef1c s\u1ef1 \u0111\u01b0\u1ee3c x\u00e2y d\u1ef1ng khi nghi\u00ean c\u1ee9u giai \u0111o\u1ea1n 2 SANRECO v\u01b0\u1ee3t qu\u00e1 50% tuy\u1ec3n d\u1ee5ng v\u00e0 ph\u1ea3n h\u1ed3i t\u00edch c\u1ef1c t\u1eeb c\u01a1 quan qu\u1ea3n l\u00fd cho zerlasiran. C\u1ed5 phi\u1ebfu \u0111\u1ea1t 6,20 USD v\u00e0o cu\u1ed1i th\u00e1ng 7 tr\u01b0\u1edbc khi \u1ed5n \u0111\u1ecbnh quanh m\u1ee9c hi\u1ec7n t\u1ea1i.<\/p>\n<p>Bi\u1ebfn \u0111\u1ed9ng n\u00e0y kh\u00f4ng d\u00e0nh cho ng\u01b0\u1eddi y\u1ebfu tim nh\u01b0ng t\u1ea1o c\u01a1 h\u1ed9i cho c\u00e1c nh\u00e0 \u0111\u1ea7u t\u01b0 chi\u1ebfn l\u01b0\u1ee3c hi\u1ec3u chu k\u1ef3 c\u00f4ng ngh\u1ec7 sinh h\u1ecdc.<\/p>\n<h2>D\u1ef1 B\u00e1o Gi\u00e1: Tri\u1ec3n V\u1ecdng 2025-2030<\/h2>\n<p>D\u1ef1a tr\u00ean s\u1ef1 \u0111\u1ed3ng thu\u1eadn c\u1ee7a c\u00e1c nh\u00e0 ph\u00e2n t\u00edch hi\u1ec7n t\u1ea1i v\u00e0 c\u00e1c c\u1ed9t m\u1ed1c l\u00e2m s\u00e0ng, t\u01b0\u01a1ng lai c\u00f3 th\u1ec3 nh\u01b0 sau:<\/p>\n<ul>\n<li><strong>Cu\u1ed1i n\u0103m 2025<\/strong>: M\u1ee5c ti\u00eau trung b\u00ecnh <strong>33,83 USD<\/strong> (t\u0103ng 563%) v\u1edbi \u01b0\u1edbc t\u00ednh cao l\u00ean \u0111\u1ebfn <strong>75,00 USD<\/strong> (<a href=\"https:\/\/www.marketbeat.com\/stocks\/NASDAQ\/SLN\/forecast\/\">D\u1ef1 B\u00e1o MarketBeat<\/a>). \u0110\u1ed9ng l\u1ef1c ch\u00ednh s\u1ebd l\u00e0 ho\u00e0n th\u00e0nh tuy\u1ec3n d\u1ee5ng \u0111\u1ea7y \u0111\u1ee7 giai \u0111o\u1ea1n 2 SANRECO.<\/li>\n<li><strong>D\u1ef1 b\u00e1o 2026<\/strong>: V\u00f9ng <strong>40-60 USD<\/strong> gi\u1ea3 \u0111\u1ecbnh d\u1eef li\u1ec7u giai \u0111o\u1ea1n 2 t\u00edch c\u1ef1c v\u00e0 kh\u1ea3 n\u0103ng c\u00f4ng b\u1ed1 h\u1ee3p t\u00e1c ph\u00e1t tri\u1ec3n giai \u0111o\u1ea1n 3 cho zerlasiran.<\/li>\n<li><strong>Tri\u1ec3n v\u1ecdng 2028<\/strong>: Ti\u1ec1m n\u0103ng <strong>80-120 USD<\/strong> n\u1ebfu divesiran \u0111\u01b0\u1ee3c ph\u00ea duy\u1ec7t v\u00e0 th\u00e0nh c\u00f4ng th\u01b0\u01a1ng m\u1ea1i trong \u0111i\u1ec1u tr\u1ecb \u0111a h\u1ed3ng c\u1ea7u nguy\u00ean ph\u00e1t.<\/li>\n<li><strong>T\u1ea7m nh\u00ecn 2030<\/strong>: C\u00f3 th\u1ec3 \u0111\u1ea1t <strong>150 USD+<\/strong> v\u1edbi nhi\u1ec1u li\u1ec7u ph\u00e1p \u0111\u01b0\u1ee3c ph\u00ea duy\u1ec7t v\u00e0 m\u1edf r\u1ed9ng danh m\u1ee5c d\u1ef1a tr\u00ean n\u1ec1n t\u1ea3ng mRNAi GOLD\u2122 c\u1ee7a h\u1ecd.<\/li>\n<\/ul>\n<p><strong>K\u1ebft lu\u1eadn<\/strong>: MUA M\u1ea0NH cho c\u00e1c nh\u00e0 \u0111\u1ea7u t\u01b0 ch\u1ecbu r\u1ee7i ro v\u1edbi t\u1ea7m nh\u00ecn 3-5 n\u0103m.<\/p>\n<h2>Ph\u00e2n T\u00edch R\u1ee7i Ro: \u0110i\u1ec1u H\u01b0\u1edbng Bi\u1ebfn \u0110\u1ed9ng C\u00f4ng Ngh\u1ec7 Sinh H\u1ecdc<\/h2>\n<h3>C\u00e1c Y\u1ebfu T\u1ed1 R\u1ee7i Ro Cao<\/h3>\n<ul>\n<li><strong>R\u1ee7i Ro Th\u1ea5t B\u1ea1i Th\u1eed Nghi\u1ec7m L\u00e2m S\u00e0ng<\/strong>: Gi\u1ea3m 21,81% v\u00e0o th\u00e1ng 1 n\u0103m 2025 cho th\u1ea5y k\u1ebft qu\u1ea3 ti\u00eau c\u1ef1c c\u00f3 th\u1ec3 g\u00e2y thi\u1ec7t h\u1ea1i l\u1edbn (<a href=\"https:\/\/tickeron.com\/trading-investing-101\/slxn-stock-surges-2414-in-2025-what-drove-the-rally-and-can-it-continue\/\">Tickeron<\/a>)<\/li>\n<li><strong>Kh\u1ea3 N\u0103ng T\u00e0i Ch\u00ednh B\u1ec1n V\u1eefng<\/strong>: Bi\u00ean l\u1ee3i nhu\u1eadn \u00e2m v\u00e0 t\u1ed1c \u0111\u1ed9 ti\u00eau ti\u1ec1n m\u1eb7t cao c\u1ea7n \u0111\u01b0\u1ee3c theo d\u00f5i ch\u1eb7t ch\u1ebd<\/li>\n<li><strong>R\u00e0o C\u1ea3n Ph\u00e1p L\u00fd<\/strong>: Ph\u00ea duy\u1ec7t FDA kh\u00f4ng bao gi\u1edd \u0111\u01b0\u1ee3c \u0111\u1ea3m b\u1ea3o, \u0111\u1eb7c bi\u1ec7t v\u1edbi c\u00e1c li\u1ec7u ph\u00e1p \u0111\u1ea7u ti\u00ean trong lo\u1ea1i<\/li>\n<li><strong>C\u1ea1nh Tranh<\/strong>: C\u00e1c c\u00f4ng ty d\u01b0\u1ee3c l\u1edbn h\u01a1n ph\u00e1t tri\u1ec3n c\u00e1c li\u1ec7u ph\u00e1p nh\u1eafm m\u1ee5c ti\u00eau KRAS t\u01b0\u01a1ng t\u1ef1<\/li>\n<\/ul>\n<h3>Y\u1ebfu T\u1ed1 T\u00edch C\u1ef1c Cho N\u0103m 2025<\/h3>\n<ul>\n<li><strong>Ho\u00e0n Th\u00e0nh Giai \u0110o\u1ea1n 2 SANRECO<\/strong>: D\u1ef1 ki\u1ebfn tuy\u1ec3n \u0111\u1ee7 v\u00e0o cu\u1ed1i n\u0103m 2025<\/li>\n<li><strong>C\u01a1 H\u1ed9i H\u1ee3p T\u00e1c<\/strong>: \u0110ang th\u1ea3o lu\u1eadn t\u00edch c\u1ef1c cho ph\u00e1t tri\u1ec3n giai \u0111o\u1ea1n 3 zerlasiran<\/li>\n<li><strong>D\u1eef Li\u1ec7u Divesiran<\/strong>: K\u1ebft qu\u1ea3 giai \u0111o\u1ea1n 1 b\u1ed5 sung cho th\u1ea5y ti\u1ec1m n\u0103ng \u0111i\u1ec1u tr\u1ecb \u0111a h\u1ed3ng c\u1ea7u nguy\u00ean ph\u00e1t<\/li>\n<li><strong>V\u1ed1n D\u1ef1 Tr\u1eef<\/strong>: V\u1ecb th\u1ebf ti\u1ec1n m\u1eb7t tr\u00ean 136 tri\u1ec7u USD k\u00e9o d\u00e0i \u0111\u1ebfn n\u0103m 2028<\/li>\n<\/ul>\n<h2>Ng\u01b0\u1eddi M\u1edbi B\u1eaft \u0110\u1ea7u N\u00ean L\u00e0m G\u00ec H\u00f4m Nay?<\/h2>\n<ol>\n<li><strong>B\u1eaft \u0110\u1ea7u Nh\u1ecf<\/strong>: Ph\u00e2n b\u1ed5 kh\u00f4ng qu\u00e1 2-5% danh m\u1ee5c cho c\u00e1c c\u1ed5 phi\u1ebfu c\u00f4ng ngh\u1ec7 sinh h\u1ecdc r\u1ee7i ro cao nh\u01b0 SLN<\/li>\n<li><strong>Trung B\u00ecnh Gi\u00e1 \u0110\u00f4 La<\/strong>: Thay v\u00ec mua m\u1ed9t l\u1ea7n l\u1edbn, h\u00e3y c\u00e2n nh\u1eafc \u0111\u1ea7u t\u01b0 nh\u1ecf \u0111\u1ec1u \u0111\u1eb7n \u0111\u1ec3 gi\u1ea3m r\u1ee7i ro th\u1eddi \u0111i\u1ec3m<\/li>\n<li><strong>\u0110\u1eb7t M\u1ee9c C\u1ea3nh B\u00e1o Gi\u00e1<\/strong>: \u0110\u1eb7t c\u1ea3nh b\u00e1o gi\u00e1 t\u1ea1i 4,50 USD (h\u1ed7 tr\u1ee3) v\u00e0 6,50 USD (kh\u00e1ng c\u1ef1) \u0111\u1ec3 b\u1eaft c\u01a1 h\u1ed9i<\/li>\n<li><strong>Theo D\u00f5i C\u00e1c C\u1ed9t M\u1ed1c L\u00e2m S\u00e0ng<\/strong>: \u0110\u00e1nh d\u1ea5u ng\u00e0y c\u00f4ng b\u1ed1 l\u1ee3i nhu\u1eadn 13 th\u00e1ng 11 v\u00e0 theo d\u00f5i c\u1eadp nh\u1eadt tuy\u1ec3n d\u1ee5ng SANRECO<\/li>\n<\/ol>\n<p>L\u1eddi khuy\u00ean h\u00e0i h\u01b0\u1edbc t\u1eeb c\u00e1c nh\u00e0 \u0111\u1ea7u t\u01b0 k\u1ef3 c\u1ef1u: &#8220;Giao d\u1ecbch SLN gi\u1ed1ng nh\u01b0 h\u1eb9n h\u00f2 v\u1edbi m\u1ed9t nh\u00e0 khoa h\u1ecdc t\u00e0i ba \u2014 c\u1ef1c k\u1ef3 th\u00fa v\u1ecb khi c\u00e1c th\u00ed nghi\u1ec7m th\u00e0nh c\u00f4ng, nh\u01b0ng h\u00e3y chu\u1ea9n b\u1ecb cho m\u1ed9t v\u00e0i th\u1ea5t b\u1ea1i n\u1ed5 tung tr\u00ean \u0111\u01b0\u1eddng \u0111i!&#8221;<\/p>\n<h2>C\u00e1ch Mua C\u1ed5 Phi\u1ebfu Silence Therapeutics plc (SLN) &#8211; T\u1eebng B\u01b0\u1edbc<\/h2>\n<table>\n<thead>\n<tr>\n<th>B\u01b0\u1edbc<\/th>\n<th>H\u00e0nh \u0110\u1ed9ng<\/th>\n<th>T\u1ea1i Sao Quan Tr\u1ecdng<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>1<\/td>\n<td>Ch\u1ecdn N\u1ec1n T\u1ea3ng Giao D\u1ecbch<\/td>\n<td>\u0110\u1ea3m b\u1ea3o n\u1ec1n t\u1ea3ng c\u00f3 danh s\u00e1ch NASDAQ v\u00e0 h\u1ed7 tr\u1ee3 mua c\u1ed5 phi\u1ebfu l\u1ebb<\/td>\n<\/tr>\n<tr>\n<td>2<\/td>\n<td>Ho\u00e0n Th\u00e0nh X\u00e1c Minh T\u00e0i Kho\u1ea3n<\/td>\n<td>H\u1ea7u h\u1ebft n\u1ec1n t\u1ea3ng y\u00eau c\u1ea7u ID v\u00e0 b\u1eb1ng ch\u1ee9ng \u0111\u1ecba ch\u1ec9<\/td>\n<\/tr>\n<tr>\n<td>3<\/td>\n<td>N\u1ea1p Ti\u1ec1n V\u00e0o T\u00e0i Kho\u1ea3n<\/td>\n<td>B\u1eaft \u0111\u1ea7u v\u1edbi s\u1ed1 ti\u1ec1n b\u1ea1n c\u1ea3m th\u1ea5y tho\u1ea3i m\u00e1i khi r\u1ee7i ro<\/td>\n<\/tr>\n<tr>\n<td>4<\/td>\n<td>T\u00ecm ki\u1ebfm &#8220;SLN&#8221;<\/td>\n<td>S\u1eed d\u1ee5ng m\u00e3 ch\u1ee9ng kho\u00e1n, kh\u00f4ng ph\u1ea3i t\u00ean \u0111\u1ea7y \u0111\u1ee7 c\u00f4ng ty<\/td>\n<\/tr>\n<tr>\n<td>5<\/td>\n<td>Ch\u1ecdn Lo\u1ea1i L\u1ec7nh<\/td>\n<td>D\u00f9ng l\u1ec7nh gi\u1edbi h\u1ea1n \u0111\u1ec3 ki\u1ec3m so\u00e1t gi\u00e1 v\u00e0o<\/td>\n<\/tr>\n<tr>\n<td>6<\/td>\n<td>Xem L\u1ea1i Chi Ti\u1ebft L\u1ec7nh<\/td>\n<td>Ki\u1ec3m tra ph\u00ed hoa h\u1ed3ng v\u00e0 ng\u00e0y thanh to\u00e1n<\/td>\n<\/tr>\n<tr>\n<td>7<\/td>\n<td>Th\u1ef1c Hi\u1ec7n Mua<\/td>\n<td>X\u00e1c nh\u1eadn giao d\u1ecbch v\u00e0 thi\u1ebft l\u1eadp theo d\u00f5i danh m\u1ee5c<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>T\u1ea1i Sao Pocket Option Thu H\u00fat Nh\u00e0 \u0110\u1ea7u T\u01b0 M\u1edbi<\/h2>\n<p>\u0110\u1ed1i v\u1edbi nh\u1eefng ng\u01b0\u1eddi m\u1edbi b\u1eaft \u0111\u1ea7u h\u00e0nh tr\u00ecnh \u0111\u1ea7u t\u01b0, Pocket Option cung c\u1ea5p nhi\u1ec1u l\u1ee3i th\u1ebf gi\u00fap vi\u1ec7c tham gia th\u1ecb tr\u01b0\u1eddng b\u1edbt \u00e1p l\u1ef1c:<\/p>\n<ul>\n<li><strong>S\u1ed1 Ti\u1ec1n N\u1ea1p T\u1ed1i Thi\u1ec3u Ch\u1ec9 5 USD<\/strong> &#8211; B\u1ea1n c\u00f3 th\u1ec3 b\u1eaft \u0111\u1ea7u v\u1edbi g\u1ea7n nh\u01b0 b\u1ea5t k\u1ef3 s\u1ed1 ti\u1ec1n n\u00e0o, r\u1ea5t ph\u00f9 h\u1ee3p \u0111\u1ec3 th\u1eed nghi\u1ec7m chi\u1ebfn l\u01b0\u1ee3c m\u00e0 kh\u00f4ng c\u1ea7n cam k\u1ebft t\u00e0i ch\u00ednh l\u1edbn.<\/li>\n<li><strong>Quy Tr\u00ecnh X\u00e1c Minh Nhanh<\/strong> &#8211; Ho\u00e0n th\u00e0nh KYC ch\u1ec9 v\u1edbi m\u1ed9t t\u00e0i li\u1ec7u t\u1ea3i l\u00ean v\u00e0 b\u1eaft \u0111\u1ea7u giao d\u1ecbch trong v\u00e0i ph\u00fat thay v\u00ec v\u00e0i ng\u00e0y.<\/li>\n<li><strong>Nhi\u1ec1u Ph\u01b0\u01a1ng Th\u1ee9c R\u00fat Ti\u1ec1n<\/strong> &#8211; Truy c\u1eadp l\u1ee3i nhu\u1eadn qua h\u00e0ng tr\u0103m ph\u01b0\u01a1ng th\u1ee9c bao g\u1ed3m ti\u1ec1n \u0111i\u1ec7n t\u1eed, v\u00ed \u0111i\u1ec7n t\u1eed v\u00e0 ng\u00e2n h\u00e0ng truy\u1ec1n th\u1ed1ng.<\/li>\n<\/ul>\n<p>Giao di\u1ec7n th\u00e2n thi\u1ec7n v\u1edbi ng\u01b0\u1eddi d\u00f9ng c\u00f9ng v\u1edbi r\u00e0o c\u1ea3n gia nh\u1eadp th\u1ea5p khi\u1ebfn n\u1ec1n t\u1ea3ng n\u00e0y l\u00fd t\u01b0\u1edfng cho c\u00e1c nh\u00e0 \u0111\u1ea7u t\u01b0 mu\u1ed1n x\u00e2y d\u1ef1ng v\u1ecb th\u1ebf trong c\u00e1c c\u00f4ng ty ti\u1ec1m n\u0103ng nh\u01b0 Silence Therapeutics m\u00e0 kh\u00f4ng b\u1ecb ph\u1ee9c t\u1ea1p qu\u00e1 m\u1ee9c.<\/p>\n<h2>T\u1ed5ng Quan C\u00f4ng Ty: Silence Therapeutics N\u0103m 2025<\/h2>\n<p>Silence Therapeutics \u0111\u1ee9ng \u1edf v\u1ecb tr\u00ed ti\u00ean phong trong \u0111\u1ed5i m\u1edbi y h\u1ecdc di truy\u1ec1n. C\u00f4ng ty chuy\u00ean v\u1ec1 li\u1ec7u ph\u00e1p siRNA (RNA can thi\u1ec7p nh\u1ecf) s\u1eed d\u1ee5ng n\u1ec1n t\u1ea3ng \u0111\u1ed9c quy\u1ec1n mRNAi GOLD\u2122 \u0111\u1ec3 nh\u1eafm ch\u00ednh x\u00e1c c\u00e1c gen g\u00e2y b\u1ec7nh.<\/p>\n<p><strong>Tr\u1ecdng T\u00e2m Hi\u1ec7n T\u1ea1i<\/strong>: \u0110\u1ea9y m\u1ea1nh ph\u00e1t tri\u1ec3n divesiran qua c\u00e1c th\u1eed nghi\u1ec7m giai \u0111o\u1ea1n 2 cho b\u1ec7nh \u0111a h\u1ed3ng c\u1ea7u nguy\u00ean ph\u00e1t, m\u1ed9t r\u1ed1i lo\u1ea1n m\u00e1u hi\u1ebfm \u1ea3nh h\u01b0\u1edfng kho\u1ea3ng 100.000 b\u1ec7nh nh\u00e2n ch\u1ec9 ri\u00eang t\u1ea1i M\u1ef9. Li\u1ec7u ph\u00e1p n\u00e0y c\u00f3 ti\u1ec1m n\u0103ng lo\u1ea1i b\u1ecf nhu c\u1ea7u l\u1ea5y m\u00e1u \u0111\u1ecbnh k\u1ef3 \u2014 c\u1ea3i thi\u1ec7n \u0111\u00e1ng k\u1ec3 ch\u1ea5t l\u01b0\u1ee3ng cu\u1ed9c s\u1ed1ng.<\/p>\n<p><strong>V\u1ecb Th\u1ebf Th\u1ecb Tr\u01b0\u1eddng<\/strong>: L\u00e0 m\u1ed9t c\u00f4ng ty c\u00f4ng ngh\u1ec7 sinh h\u1ecdc v\u1ed1n h\u00f3a nh\u1ecf v\u1edbi gi\u00e1 tr\u1ecb th\u1ecb tr\u01b0\u1eddng 291 tri\u1ec7u USD, SLN th\u1ec3 hi\u1ec7n s\u1ef1 v\u01b0\u1ee3t tr\u1ed9i v\u1ec1 \u0111\u1ed5i m\u1edbi c\u00f4ng ngh\u1ec7 trong khi duy tr\u00ec s\u1ef1 linh ho\u1ea1t \u0111\u1ec3 nhanh ch\u00f3ng \u0111i\u1ec1u ch\u1ec9nh d\u1ef1a tr\u00ean k\u1ebft qu\u1ea3 l\u00e2m s\u00e0ng.<\/p>\n<p><strong>S\u1ef1 Th\u1eadt Th\u00fa V\u1ecb N\u0103m 2025<\/strong>: Trung t\u00e2m nghi\u00ean c\u1ee9u c\u1ee7a Silence Therapeutics \u0111\u00e3 ph\u00e1t tri\u1ec3n m\u1ed9t h\u1ec7 th\u1ed1ng AI c\u00f3 th\u1ec3 d\u1ef1 \u0111o\u00e1n m\u00f4 h\u00ecnh g\u1eadp RNA v\u1edbi \u0111\u1ed9 ch\u00ednh x\u00e1c 94% \u2014 r\u00fat ng\u1eafn th\u1eddi gian ph\u00e1t tri\u1ec3n thu\u1ed1c h\u00e0ng th\u00e1ng v\u00e0 c\u00f3 th\u1ec3 ti\u1ebft ki\u1ec7m h\u00e0ng tri\u1ec7u USD chi ph\u00ed R&#038;D. L\u1ee3i th\u1ebf c\u00f4ng ngh\u1ec7 n\u00e0y c\u00f3 th\u1ec3 c\u00e1ch m\u1ea1ng h\u00f3a t\u1ed1c \u0111\u1ed9 \u0111\u01b0a c\u00e1c li\u1ec7u ph\u00e1p m\u1edbi ra th\u1ecb tr\u01b0\u1eddng.<\/p>\n"},"faq":[{"question":"Silence Therapeutics l\u00e0 c\u00f4ng ty g\u00ec?","answer":"Silence Therapeutics l\u00e0 c\u00f4ng ty c\u00f4ng ngh\u1ec7 sinh h\u1ecdc chuy\u00ean ph\u00e1t tri\u1ec3n li\u1ec7u ph\u00e1p siRNA s\u1eed d\u1ee5ng n\u1ec1n t\u1ea3ng mRNAi GOLD\u2122 \u0111\u1ec3 nh\u1eafm m\u1ee5c ti\u00eau ch\u00ednh x\u00e1c c\u00e1c gen g\u00e2y b\u1ec7nh, t\u1eadp trung v\u00e0o c\u00e1c b\u1ec7nh hi\u1ebfm nh\u01b0 \u0111a h\u1ed3ng c\u1ea7u nguy\u00ean ph\u00e1t."},{"question":"L\u00e0m th\u1ebf n\u00e0o \u0111\u1ec3 mua c\u1ed5 phi\u1ebfu SLN?","answer":"B\u1ea1n c\u1ea7n ch\u1ecdn n\u1ec1n t\u1ea3ng giao d\u1ecbch h\u1ed7 tr\u1ee3 NASDAQ, ho\u00e0n th\u00e0nh x\u00e1c minh t\u00e0i kho\u1ea3n, n\u1ea1p ti\u1ec1n, t\u00ecm m\u00e3 c\u1ed5 phi\u1ebfu SLN, ch\u1ecdn lo\u1ea1i l\u1ec7nh, xem l\u1ea1i chi ti\u1ebft v\u00e0 th\u1ef1c hi\u1ec7n mua c\u1ed5 phi\u1ebfu."},{"question":"Gi\u00e1 c\u1ed5 phi\u1ebfu SLN hi\u1ec7n t\u1ea1i l\u00e0 bao nhi\u00eau?","answer":"T\u00ednh \u0111\u1ebfn ng\u00e0y 29 th\u00e1ng 8 n\u0103m 2025, gi\u00e1 c\u1ed5 phi\u1ebfu SLN l\u00e0 5,10 USD m\u1ed7i c\u1ed5 phi\u1ebfu."},{"question":"R\u1ee7i ro khi \u0111\u1ea7u t\u01b0 v\u00e0o SLN l\u00e0 g\u00ec?","answer":"C\u00e1c r\u1ee7i ro ch\u00ednh bao g\u1ed3m th\u1ea5t b\u1ea1i th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng, kh\u1ea3 n\u0103ng t\u00e0i ch\u00ednh kh\u00f4ng b\u1ec1n v\u1eefng, r\u00e0o c\u1ea3n ph\u00e1p l\u00fd t\u1eeb FDA v\u00e0 c\u1ea1nh tranh t\u1eeb c\u00e1c c\u00f4ng ty d\u01b0\u1ee3c l\u1edbn h\u01a1n."},{"question":"Tri\u1ec3n v\u1ecdng gi\u00e1 c\u1ed5 phi\u1ebfu SLN trong t\u01b0\u01a1ng lai ra sao?","answer":"D\u1ef1 b\u00e1o gi\u00e1 SLN c\u00f3 th\u1ec3 t\u0103ng l\u00ean trung b\u00ecnh 33,83 USD v\u00e0o cu\u1ed1i n\u0103m 2025, v\u1edbi ti\u1ec1m n\u0103ng \u0111\u1ea1t 150 USD ho\u1eb7c h\u01a1n v\u00e0o n\u0103m 2030 n\u1ebfu c\u00e1c li\u1ec7u ph\u00e1p \u0111\u01b0\u1ee3c ph\u00ea duy\u1ec7t v\u00e0 th\u00e0nh c\u00f4ng th\u01b0\u01a1ng m\u1ea1i."}],"faq_source":{"label":"FAQ","type":"repeater","formatted_value":[{"question":"Silence Therapeutics l\u00e0 c\u00f4ng ty g\u00ec?","answer":"Silence Therapeutics l\u00e0 c\u00f4ng ty c\u00f4ng ngh\u1ec7 sinh h\u1ecdc chuy\u00ean ph\u00e1t tri\u1ec3n li\u1ec7u ph\u00e1p siRNA s\u1eed d\u1ee5ng n\u1ec1n t\u1ea3ng mRNAi GOLD\u2122 \u0111\u1ec3 nh\u1eafm m\u1ee5c ti\u00eau ch\u00ednh x\u00e1c c\u00e1c gen g\u00e2y b\u1ec7nh, t\u1eadp trung v\u00e0o c\u00e1c b\u1ec7nh hi\u1ebfm nh\u01b0 \u0111a h\u1ed3ng c\u1ea7u nguy\u00ean ph\u00e1t."},{"question":"L\u00e0m th\u1ebf n\u00e0o \u0111\u1ec3 mua c\u1ed5 phi\u1ebfu SLN?","answer":"B\u1ea1n c\u1ea7n ch\u1ecdn n\u1ec1n t\u1ea3ng giao d\u1ecbch h\u1ed7 tr\u1ee3 NASDAQ, ho\u00e0n th\u00e0nh x\u00e1c minh t\u00e0i kho\u1ea3n, n\u1ea1p ti\u1ec1n, t\u00ecm m\u00e3 c\u1ed5 phi\u1ebfu SLN, ch\u1ecdn lo\u1ea1i l\u1ec7nh, xem l\u1ea1i chi ti\u1ebft v\u00e0 th\u1ef1c hi\u1ec7n mua c\u1ed5 phi\u1ebfu."},{"question":"Gi\u00e1 c\u1ed5 phi\u1ebfu SLN hi\u1ec7n t\u1ea1i l\u00e0 bao nhi\u00eau?","answer":"T\u00ednh \u0111\u1ebfn ng\u00e0y 29 th\u00e1ng 8 n\u0103m 2025, gi\u00e1 c\u1ed5 phi\u1ebfu SLN l\u00e0 5,10 USD m\u1ed7i c\u1ed5 phi\u1ebfu."},{"question":"R\u1ee7i ro khi \u0111\u1ea7u t\u01b0 v\u00e0o SLN l\u00e0 g\u00ec?","answer":"C\u00e1c r\u1ee7i ro ch\u00ednh bao g\u1ed3m th\u1ea5t b\u1ea1i th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng, kh\u1ea3 n\u0103ng t\u00e0i ch\u00ednh kh\u00f4ng b\u1ec1n v\u1eefng, r\u00e0o c\u1ea3n ph\u00e1p l\u00fd t\u1eeb FDA v\u00e0 c\u1ea1nh tranh t\u1eeb c\u00e1c c\u00f4ng ty d\u01b0\u1ee3c l\u1edbn h\u01a1n."},{"question":"Tri\u1ec3n v\u1ecdng gi\u00e1 c\u1ed5 phi\u1ebfu SLN trong t\u01b0\u01a1ng lai ra sao?","answer":"D\u1ef1 b\u00e1o gi\u00e1 SLN c\u00f3 th\u1ec3 t\u0103ng l\u00ean trung b\u00ecnh 33,83 USD v\u00e0o cu\u1ed1i n\u0103m 2025, v\u1edbi ti\u1ec1m n\u0103ng \u0111\u1ea1t 150 USD ho\u1eb7c h\u01a1n v\u00e0o n\u0103m 2030 n\u1ebfu c\u00e1c li\u1ec7u ph\u00e1p \u0111\u01b0\u1ee3c ph\u00ea duy\u1ec7t v\u00e0 th\u00e0nh c\u00f4ng th\u01b0\u01a1ng m\u1ea1i."}]}},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.8 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>C\u00e1ch mua c\u1ed5 phi\u1ebfu Silence Therapeutics plc (SLN) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Silence Therapeutics plc (SLN)<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-silence-therapeutics\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"C\u00e1ch mua c\u1ed5 phi\u1ebfu Silence Therapeutics plc (SLN) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Silence Therapeutics plc (SLN)\" \/>\n<meta property=\"og:description\" content=\"text\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-silence-therapeutics\/\" \/>\n<meta property=\"og:site_name\" content=\"Pocket Option blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-29T12:14:01+00:00\" \/>\n<meta name=\"author\" content=\"Signal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Signal\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-silence-therapeutics\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-silence-therapeutics\/\"},\"author\":{\"name\":\"Signal\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"headline\":\"C\u00e1ch mua c\u1ed5 phi\u1ebfu Silence Therapeutics plc (SLN) &#8211; \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Silence Therapeutics plc (SLN)\",\"datePublished\":\"2025-08-29T12:14:01+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-silence-therapeutics\/\"},\"wordCount\":23,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-silence-therapeutics\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals11.webp\",\"keywords\":[\"signal\"],\"articleSection\":[\"Signals\"],\"inLanguage\":\"vt-VT\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-silence-therapeutics\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-silence-therapeutics\/\",\"url\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-silence-therapeutics\/\",\"name\":\"C\u00e1ch mua c\u1ed5 phi\u1ebfu Silence Therapeutics plc (SLN) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Silence Therapeutics plc (SLN)\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-silence-therapeutics\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-silence-therapeutics\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals11.webp\",\"datePublished\":\"2025-08-29T12:14:01+00:00\",\"author\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"breadcrumb\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-silence-therapeutics\/#breadcrumb\"},\"inLanguage\":\"vt-VT\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-silence-therapeutics\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"vt-VT\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-silence-therapeutics\/#primaryimage\",\"url\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals11.webp\",\"contentUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals11.webp\",\"width\":1024,\"height\":576},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-silence-therapeutics\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/pocketoption.com\/blog\/vt\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"C\u00e1ch mua c\u1ed5 phi\u1ebfu Silence Therapeutics plc (SLN) &#8211; \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Silence Therapeutics plc (SLN)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/#website\",\"url\":\"https:\/\/pocketoption.com\/blog\/vt\/\",\"name\":\"Pocket Option blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pocketoption.com\/blog\/vt\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"vt-VT\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\",\"name\":\"Signal\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"vt-VT\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"caption\":\"Signal\"},\"url\":\"https:\/\/pocketoption.com\/blog\/vt\/author\/signal\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Silence Therapeutics plc (SLN) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Silence Therapeutics plc (SLN)","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-silence-therapeutics\/","og_locale":"en_US","og_type":"article","og_title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Silence Therapeutics plc (SLN) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Silence Therapeutics plc (SLN)","og_description":"text","og_url":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-silence-therapeutics\/","og_site_name":"Pocket Option blog","article_published_time":"2025-08-29T12:14:01+00:00","author":"Signal","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Signal"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-silence-therapeutics\/#article","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-silence-therapeutics\/"},"author":{"name":"Signal","@id":"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"headline":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Silence Therapeutics plc (SLN) &#8211; \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Silence Therapeutics plc (SLN)","datePublished":"2025-08-29T12:14:01+00:00","mainEntityOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-silence-therapeutics\/"},"wordCount":23,"commentCount":0,"image":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-silence-therapeutics\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals11.webp","keywords":["signal"],"articleSection":["Signals"],"inLanguage":"vt-VT","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-silence-therapeutics\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-silence-therapeutics\/","url":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-silence-therapeutics\/","name":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Silence Therapeutics plc (SLN) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Silence Therapeutics plc (SLN)","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-silence-therapeutics\/#primaryimage"},"image":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-silence-therapeutics\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals11.webp","datePublished":"2025-08-29T12:14:01+00:00","author":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"breadcrumb":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-silence-therapeutics\/#breadcrumb"},"inLanguage":"vt-VT","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-silence-therapeutics\/"]}]},{"@type":"ImageObject","inLanguage":"vt-VT","@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-silence-therapeutics\/#primaryimage","url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals11.webp","contentUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals11.webp","width":1024,"height":576},{"@type":"BreadcrumbList","@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-silence-therapeutics\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pocketoption.com\/blog\/vt\/"},{"@type":"ListItem","position":2,"name":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Silence Therapeutics plc (SLN) &#8211; \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Silence Therapeutics plc (SLN)"}]},{"@type":"WebSite","@id":"https:\/\/pocketoption.com\/blog\/vt\/#website","url":"https:\/\/pocketoption.com\/blog\/vt\/","name":"Pocket Option blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pocketoption.com\/blog\/vt\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"vt-VT"},{"@type":"Person","@id":"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe","name":"Signal","image":{"@type":"ImageObject","inLanguage":"vt-VT","@id":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","caption":"Signal"},"url":"https:\/\/pocketoption.com\/blog\/vt\/author\/signal\/"}]}},"po_author":null,"po__editor":null,"po_last_edited":null,"wpml_current_locale":"vt_VT","wpml_translations":{"pt_AA":{"locale":"pt_AA","id":358319,"slug":"how-to-buy-silence-therapeutics","post_title":"Como comprar a\u00e7\u00f5es da Silence Therapeutics plc (SLN) - Investimento em a\u00e7\u00f5es da Silence Therapeutics plc (SLN)","href":"https:\/\/pocketoption.com\/blog\/pt\/news-events\/signal\/how-to-buy-silence-therapeutics\/"}},"_links":{"self":[{"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/posts\/358325","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/users\/129"}],"replies":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/comments?post=358325"}],"version-history":[{"count":0,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/posts\/358325\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/media\/334081"}],"wp:attachment":[{"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/media?parent=358325"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/categories?post=358325"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/tags?post=358325"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}